- Home
- XXII vs APDN Comparison
XXII vs APDN Comparison
Compare XXII & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- APDN
- Stock Information
- Founded
- XXII 1998
- APDN 1983
- Country
- XXII United States
- APDN United States
- Employees
- XXII N/A
- APDN N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- APDN Other Consumer Services
- Sector
- XXII Health Care
- APDN Consumer Discretionary
- Exchange
- XXII Nasdaq
- APDN Nasdaq
- Market Cap
- XXII 2.0M
- APDN 1.7M
- IPO Year
- XXII N/A
- APDN N/A
- Fundamental
- Price
- XXII $1.65
- APDN $2.89
- Analyst Decision
- XXII
- APDN
- Analyst Count
- XXII 0
- APDN 0
- Target Price
- XXII N/A
- APDN N/A
- AVG Volume (30 Days)
- XXII 200.6K
- APDN 68.6K
- Earning Date
- XXII 08-14-2025
- APDN 08-26-2025
- Dividend Yield
- XXII N/A
- APDN N/A
- EPS Growth
- XXII N/A
- APDN N/A
- EPS
- XXII N/A
- APDN 211.51
- Revenue
- XXII $21,362,000.00
- APDN $3,743,063.00
- Revenue This Year
- XXII $22.41
- APDN $57.08
- Revenue Next Year
- XXII $76.35
- APDN $40.00
- P/E Ratio
- XXII N/A
- APDN $0.01
- Revenue Growth
- XXII N/A
- APDN 55.60
- 52 Week Low
- XXII $1.72
- APDN $2.81
- 52 Week High
- XXII $1,571.13
- APDN $1,410.00
- Technical
- Relative Strength Index (RSI)
- XXII 20.98
- APDN 26.11
- Support Level
- XXII $1.72
- APDN $2.81
- Resistance Level
- XXII $2.45
- APDN $3.30
- Average True Range (ATR)
- XXII 0.11
- APDN 0.23
- MACD
- XXII 0.16
- APDN -0.02
- Stochastic Oscillator
- XXII 0.00
- APDN 7.09
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.